The Claim
Advanced glycation end products (AGEs) binding to the receptor for AGEs (RAGE) on chondrocytes activate NF-κB, increase oxidative stress, and upregulate matrix-degrading enzymes MMP-13 and ADAMTS-5, leading to cartilage breakdown in diabetes-related osteoarthritis.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In diabetes-related osteoarthritis, AGEs binding to RAGE on cartilage cells trigger a biochemical cascade that increases oxidative stress and elevates levels of enzymes that break down cartilage matrix.
See the scientific wording
Advanced glycation end products (AGEs) bind to the receptor for AGEs (RAGE) on chondrocytes, activating NF-κB and increasing oxidative stress, which upregulates matrix-degrading enzymes such as MMP-13 and ADAMTS-5, contributing to cartilage breakdown in the context of diabetes-related osteoarthritis.
In diabetes, excess sugar attaches to cartilage proteins, making the tissue stiff and triggering a stress signal in joint cells. This stiffness, along with the sugar-modified proteins binding to a receptor on the cells, turns on a molecular switch called NF-κB. Once activated, NF-κB forces the cells to produce enzymes that chew up the cartilage matrix, leading to joint damage.
What the research says
1 studyIn people with diabetes, sugar molecules stick to cartilage proteins, making them stiff and damaged. This damage is linked to worse joint wear and tear, suggesting it triggers harmful processes that break down cartilage.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.